Previous Close | 8.30 |
Open | 0.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 0.00 - 0.00 |
52 Week Range | |
Volume | |
Avg. Volume | 5,061,213 |
Market Cap | 5.057B |
Beta (5Y Monthly) | 0.67 |
PE Ratio (TTM) | 92.64 |
EPS (TTM) | 0.09 |
Earnings Date | May 07, 2024 - May 13, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Jun 03, 2021 |
1y Target Est | 18.71 |
Subscribe to Yahoo Finance Plus to view Fair Value for GRF.MC
(Bloomberg) -- Grifols SA shares dropped as investors evaluated a regulatory review of the Spanish bio-science company’s financial reports, which found “relevant deficiencies” but no major accounting mistakes.Most Read from BloombergNY Gears Up to Seize Trump Westchester Assets If Fraud Fine Is UnpaidBaltimore Wants to Sell Hundreds of Vacant Homes for $1 EachWhat Happens If Trump Can’t Post His $454 Million BondChina Scrutinizes PwC Role in $78 Billion Evergrande Fraud CaseYemen’s Houthis Tell
Read about Novo Nordisk, Grifols, Shandong Weigao and more in the latest Market Talks covering the Health Care sector.
Europe's main stock indices were flat on Friday, but notched strong gains over the week that saw record highs from German and French shares, while investors also analysed a U.S. jobs report for clues on the global monetary policy outlook. Technology lost 1.6% after BE Semiconductor slumped 16.1% on a media report that Joint Electron Device Engineering Council lowered certain chip standards which might delay investments into hybrid bonding technology.